Search results for "ischemic"

showing 10 items of 346 documents

“Handbook” per la valutazione preoperatoria con CardioRM dei pazienti con insufficienza mitralica post-ischemica.

2010

insufficienza mitralica post-ischemica.Settore MED/36 - Diagnostica Per Immagini E RadioterapiaCardioRM
researchProduct

Impatto dell'insufficienza mitralica funzionale sulla prognosi dei pazienti affetti da cardiopatia ischemica

2015

insufficienza mitralicacardiopatia ischemicaprognosi
researchProduct

Akūta išēmiska insulta pacientu aprūpe pēc intravenozās trombolīzes

2019

Bakalaura darba tēma – „Akūta išēmiska insulta pacientu aprūpe pēc intravenozās trombolīzes”. Bakalaura darbā tika izvirzīts mērķis: izpētīt akūta išēmiska insulta pacientu aprūpi pēc intravenozās trombolīzes. Mērķa sasniegšanai tika sastādīti uzdevumi un izvirzīts jautājums: Kādi ir aprūpes principi pēc intravenozās trombolīzes pacientiem ar akūtu išēmisku insultu? Darbs sastāv no divām daļām - teorētiskās un empīriskās. Teorētiskā daļā analizēta literatūra par insultu, insulta radītajām sekām un aprūpi pēc intravenozas trombolīzes. Pētījuma realizēšanai tika izmantota kvalitatīvā pētniecības metode – intervija. Tika intervētas 6 praktizējošas māsas. Pētījums tika veikts vienā no lielākaji…

intravenozā trombolīzeaprūpeischemic strokemāsaakūts išēmisks insultsMedicīna
researchProduct

Bestimmung der myokardialen Perfusionsreserve bei KHK-Patienten mit der kontrastmittelverstärkten MRT: Ein Vergleich zwischen semiquantitativer und q…

2002

OBJECTIVE Comparison between two semiquantitative methods and a quantitative evaluation of myocardial blood flow (MBF) for assessment of myocardial perfusion reserve (MPR) in patients with CAD. MATERIAL AND METHODS 9 patients with coronary stenoses > 50 % were examined with an ECG-gated Saturation Recovery Turbo FLASH sequence by using Gd-DTPA as contrast agent (CA). The entive measurements were performed both during rest and hyperemia induced by adenosine. The up-slopes of the signal-time S(t) curves in the myocardium and left ventricular (LV) cavity were evaluated by a linear fit. MPR was calculated from the original up-slopes of the myocardial S(t) curves and from the up-slopes, which we…

medicine.diagnostic_testbusiness.industryIschemic myocardiumIschemiaSaturation recoveryMagnetic resonance imagingBlood flowPerfusion reservemedicine.diseaseMedicineRadiology Nuclear Medicine and imagingIn patientbusinessNuclear medicinePerfusionRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Impairment of the modulatory role of nitric oxide on the endothelin-1-elicited contraction of cerebral arteries: a pathogenetic factor in cerebral va…

1997

OBJECTIVE: Nitric oxide (NO) and endothelin-1 (ET-1) are two endothelium-derived factors probably involved in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage (SAH). Our aim was twofold, i.e., to ascertain whether endothelial and nonendothelial NO modulates the contractile response of cerebral arteries to ET-1 and to analyze whether this relationship might be impaired after experimental SAH. METHODS: Rings of middle cerebral artery from goats in the control group and from goats with SAH were set up for isometric tension recordings. SAH was induced 3 days before the experiments by infusion of 10 ml of autologous arterial blood through a catheter previously inserted into t…

medicine.hormonemedicine.medical_specialtySubarachnoid hemorrhageEndotheliumCerebral arteriesNitric OxideEndothelinsCerebral vasospasmInternal medicinemedicine.arterymedicineAnimalscardiovascular diseasesEndothelin-1business.industryVascular diseaseGoatsVasospasmCerebral ArteriesSubarachnoid Hemorrhagemedicine.diseasenervous system diseasesMicroscopy Electronmedicine.anatomical_structureIschemic Attack TransientVasoconstrictionAnesthesiaMiddle cerebral arterycardiovascular systemCardiologySurgeryNeurology (clinical)Endothelium VascularbusinessNeurosurgery
researchProduct

Update on Ischemic Heart Disease and Critical Care Cardiology

2014

This article summarizes the main developments reported in 2013 on ischemic heart disease, together with the most important innovations in the management of acute cardiac patients. 3.792 JCR (2014) Q2, 34/123 Cardiac & cardiovascular systems UEM

medicine.medical_specialtyAcute coronary syndromeCritical Caremedicine.medical_treatmentEnfermedad cardiovascularMyocardial InfarctionMyocardial IschemiaDiseaseCardiologíaTratamiento médicoPercutaneous Coronary InterventionSex FactorsSex factorsInternal medicinemedicineHumansMyocardial infarctionAcute Coronary SyndromeIntensive care medicinePatofisiologíaSistema cardiovascularbusiness.industryAge FactorsPercutaneous coronary interventionGeneral Medicinemedicine.diseasePrognosisPrimary PreventionConventional PCICardiologycardiovascular systemPlatelet aggregation inhibitorInfarto de miocardiobusinessIschemic heartPlatelet Aggregation InhibitorsRevista Española de Cardiología (English Edition)
researchProduct

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome

2021

Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CC…

medicine.medical_specialtyAcute coronary syndromeIschemic heart diseasemedicine.medical_treatmentstress cardiac magnetic resonancelcsh:MedicineChronic coronary syndromeReviewischemiaDisease030204 cardiovascular system & hematologyRevascularizationCoronary artery diseaseCoronary artery disease03 medical and health sciences0302 clinical medicineIschemiaInternal medicineMedicine030212 general & internal medicineCause of deathStress cardiac magnetic resonancechronic coronary syndromebusiness.industryMortality ratelcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseischemic heart diseaseMyocardial revascularizationmyocardial revascularizationConventional PCICardiologybusinesscoronary artery diseaseJournal of Clinical Medicine
researchProduct

Actualización en cardiopatía isquémica y cuidados críticos cardiológicos

2013

This article summarizes the main developments reported during the year 2012 concerning ischemic heart disease, together with the most relevant innovations in the management of acute cardiac patients. Full English text available from: www.revespcardiol.org/en.

medicine.medical_specialtyAcute coronary syndromebusiness.industryInternal medicineCardiologymedicineMyocardial infarctionDiseaseCardiology and Cardiovascular Medicinebusinessmedicine.diseaseIschemic heartRevista Española de Cardiología
researchProduct

Clinical History and Detectable Troponin Concentrations below the 99th Percentile for Risk Stratification of Patients with Chest Pain and First Norma…

2021

Decision-making is challenging in patients with chest pain and normal high-sensitivity cardiac troponin T (hs-cTnT

medicine.medical_specialtyAcute coronary syndromechest painclinical evaluationmacromolecular substances030204 cardiovascular system & hematologyChest painArticleacute coronary syndrome03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpoint030212 general & internal medicineMyocardial infarctionbiologybusiness.industrytroponinHazard ratioRGeneral MedicineEmergency departmentmedicine.diseaseTroponinischemic heart diseaseConfidence intervalbiology.proteinCardiologyMedicinemedicine.symptombusinessJournal of Clinical Medicine
researchProduct

Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease

2018

Cardiovascular diseases (CVD) including coronary artery disease (CAD) and ischemic heart disease (IHD) are the main cause of mortality in industrialized countries. Although it is well known that there is a difference in the risk of these diseases in women and men, current therapy does not consider the sexual dimorphism; i.e., differences in anatomical structures and metabolism of tissues. Here, we discuss how genetic, epigenetic, hormonal, cellular or molecular factors may explain the different CVD risk, especially in high-risk groups such as women with diabetes. We analyze whether sex may modify the effects of diabetes at risk of CAD. Finally, we discuss current diagnostic techniques in th…

medicine.medical_specialtyAnatomical structureslcsh:MedicineReviewDisease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusgendercell signalingsexSettore MED/05 - Patologia ClinicaMedicinecardiovascular diseasesCoronary atherosclerosis030304 developmental biology0303 health sciencesdiabetesbusiness.industrylcsh:Rbiomarkers; cell signaling; coronary artery disease; diabetes; gender; sex; womenbiomarkersGeneral Medicinemedicine.diseaseSexual dimorphismdiabeteCardiologybiomarkerwomenbusinessIschemic heartDeveloped countrycoronary artery diseaseJournal of Clinical Medicine
researchProduct